Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
17.01.2006 14:15:00

TLCVision Announces 11th Ambulatory Surgery Center, With Acquisition Of Liberty Eye Surgical Center In Philadelphia, Pennsylvania

TLC Vision Corporation (TSX:TLC)(NASDAQ:TLCV), NorthAmerica's premier eye care services company, announced today theacquisition of a significant minority ownership interest in LibertyEye Surgical Center, a six-physician owned ambulatory surgery center(ASC) located in Philadelphia, Pennsylvania. This ASC is wellrecognized in its market place and currently performs over 4,000procedures annually in a two-room operating facility. Liberty EyeSurgical Center becomes the 11th ASC for TLCVision.

"TLCVision continues to deliver on its eye care diversificationstrategy," said Jim Wachtman, President and CEO. "This acquisition isexpected to be immediately accretive to earnings and allows us theopportunity to work with six highly respected ophthalmologists in thePhiladelphia area."

Cataract procedures are most common among the senior populationand, out of the top 10 major markets in the country, Philadelphia hasthe highest percentage of adults age 65+. Along with the Kremer ASC,acquired in July 2005, these acquisitions now provide TLCVision astrong presence in the large Philadelphia cataract market.

TLCVision acquired 49% of the assets of Liberty Eye SurgicalCenter. The six ophthalmologist partners include Joanna Fisher, M.D.,Dennis Khoury, M.D., Richard Naids, M.D., John Siliquini, M.D.,Mustapha Shayegan, M.D., and Dennis Slochower, M.D., Managing Partner.

About TLCVision

TLCVision is North America's premier eye care services company,providing eye doctors with the tools and technologies needed todeliver high-quality patient care. Through its centers management andtechnology access service models, and its managed care contractingstrength, TLCVision maintains leading positions in Refractive,Cataract, and AMD markets. More information about TLCVision can befound on the web site at www.tlcv.com.

Forward Looking Statements

This press release contains certain forward-looking statementswithin the meaning of Section 27A of the U.S. Securities Act of 1933and Section 21E of the U.S. Securities Exchange Act of 1934, whichstatements can be identified by the use of forward lookingterminology, such as "may", "will", "expect", "intend", "anticipate","estimate", "predict", "plans" or "continue" or the negative thereofor other variations thereon or comparable terminology referring tofuture events or results. The Company's actual results could differmaterially from those anticipated in these forward-looking statementsas a result of numerous factors, including the timing of expenditures,effects of competition, changes to pricing, acquisitions and expansionopportunities, any of which could cause actual results to varymaterially from current results or TLCVision's anticipated futureresults. See the Company's reports filed with the Canadian SecuritiesRegulators and the U.S. Securities and Exchange Commission from timeto time for cautionary statements identifying important factors withrespect to such forward looking statements, including certain risksand uncertainties, that could cause actual results to differmaterially from results referred to in forward looking statements.TLCVision assumes no obligation to update the information contained inthis press release.

TLC Vision Corporation (TSX:TLC) (NASDAQ:TLCV)

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu TLC Laser Eye Center Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu TLC Laser Eye Center Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 480,91 0,40%